CCG-232601

CCG-232601 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:CCG-232601;CCG 232601;CCG232601
CAS:1922099-21-5
Package:100 mg;500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Products Intro: Product Name:CCG 232601
CAS:1922099-21-5
Purity:99% Remarks:CCG 232601 is a selective and orally bioactive inhibitor of the Rho/MRTF/SRF signaling pathway (IC50 value of 0.55 μM (SRE.L assay)) as a potential antifibrotic therapeutic for systemic scleroderma. C
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Products Intro: Product Name:CCG 232601
CAS:1922099-21-5
Purity:99% Package:1mg;5mg;25mg
Company Name: Shanghai Hongye Biotechnology Co. Ltd  
Tel: 400-9205774
Email: sales@glpbio.cn
Products Intro: Product Name:CCG-232601
CAS:1922099-21-5
Purity:>98% Package:1mg;10mg;50mg;100mg;
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com
Products Intro: Product Name:CCG-232601
CAS:1922099-21-5
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
CCG-232601 Basic information
Product Name:CCG-232601
Synonyms:CCG-232601;CCG-232601 (CCG232601);3-Piperidinecarboxamide, N-(4-chlorophenyl)-5,5-difluoro-1-[3-(4-pyridinyl)benzoyl]-;N-(4-chlorophenyl)-5,5-difluoro-1-[3-(4-pyridinyl)benzoyl]-3-piperidinecarboxamide
CAS:1922099-21-5
MF:C24H20ClF2N3O2
MW:455.88
EINECS:
Product Categories:
Mol File:1922099-21-5.mol
CCG-232601 Structure
CCG-232601 Chemical Properties
Boiling point 683.1±55.0 °C(Predicted)
density 1.39±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF: 30 mg/ml; DMSO: 30 mg/ml; DMSO:PBS (pH 7.2) (1:3): 0.25 mg/ml
form A crystalline solid
pka13.69±0.70(Predicted)
Safety Information
MSDS Information
CCG-232601 Usage And Synthesis
DescriptionCCG-232601 is an inhibitor of the Rho/MRTF/SRF transcriptional pathway and a derivative of CCG-203971 . CCG-232601 inhibits MRTF-dependent transcription in HEK293T cells (IC50 = 0.55 μM in a luciferase reporter assay). It also reduces expression of α-smooth muscle actin (α-SMA) in TGF-β-stimulated human dermal fibroblasts to 31% of control when used at a concentration of 10 μM. CCG-232601 (50 mg/kg) inhibits increases in dermal thickness and hydroxyproline content in a mouse model of dermal fibrosis induced by bleomycin .
CCG-232601 Preparation Products And Raw materials
Tag:CCG-232601(1922099-21-5) Related Product Information